4.6 Article

EZH2 Regulates the Developmental Timing of Effectors of the Pre-Antigen Receptor Checkpoints

Journal

JOURNAL OF IMMUNOLOGY
Volume 198, Issue 12, Pages 4682-4691

Publisher

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1700319

Keywords

-

Categories

Funding

  1. National Institutes of Health [R21 AI109233, R01 AI106352]
  2. University of Chicago Comprehensive Cancer Center [P30 CA014599]
  3. Medical Scientist Training [T32 GM007281]
  4. Leukemia and Lymphoma Society

Ask authors/readers for more resources

The histone methyltransferase EZH2 is required for B and T cell development; however, the molecular mechanisms underlying this requirement remain elusive. In a murine model of lymphoid-specific EZH2 deficiency we found that EZH2 was required for proper development of adaptive, but not innate, lymphoid cells. In adaptive lymphoid cells EZH2 prevented the premature expression of Cdkn2a and the consequent stabilization of p53, an effector of the pre-Ag receptor checkpoints. Deletion of Cdkn2a in EZH2-deficient lymphocytes prevented p53 stabilization, extended lymphocyte survival, and restored differentiation resulting in the generation of mature B and T lymphocytes. Our results uncover a crucial role for EZH2 in adaptive lymphocytes to control the developmental timing of effectors of the pre-Ag receptor checkpoints.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available